Our company is an enterprise specializing in the research and development, manufacturing and operation of BGM0504 Injection GLP 1 GIP Receptor Agonist, innovative drug, Dual GLP 1 GIP Receptor Agonist BGM0504 integrating science, industry and trade, and owning the right to import and export.Relying on our strong technical strength, modern factories and professional staff in various departments, our company has been committed to the research and development, production and sales of Incretin Analogs BGM0504 for a long time. Our commitment to sustainability and environmental responsibility underscores all aspects of our business operations. Our company is dedicated to promoting sustainable and responsible business practices. In the era of service economy, one of the focuses of competition among enterprises is service. Providing high quality service with customer satisfaction is becoming a golden key to the success of enterprises. We are committed to providing excellent customer service, ensuring that every customer is fully satisfied with our products and services. Our team is dedicated to providing outstanding customer service and support. We constantly meet the needs of our customers, create value and benefits for them, and grow together with them.
-
![Incretin Analogs BGM0504]()
Incretin Analogs BGM0504Product Name: Incretin Analogs BGM0504 Indication Type 2 diabetes mellitus; Obesity Type Innovative Drug Form Injection Target Dual GLP/GIP receptor agonist Clinical progress Phase Ⅲread more -
![BGM0504 Injection GLP-1/GIP Receptor Agonist]()
BGM0504 Injection GLP-1/GIP Receptor AgonistProduct Name: BGM0504 Injection GLP-1/GIP receptor agonist Indication Type 2 diabetes mellitus; Obesity Type Innovative Drug Form Injection Target Dual GLP/GIP receptor agonist Clinicalread more -
![Dual GLP-1/GIP Receptor Agonist BGM0504]()
Dual GLP-1/GIP Receptor Agonist BGM0504Product Name: Dual GLP-1/GIP receptor agonist BGM0504 Indication Type 2 diabetes mellitus; Obesity Type Innovative Drug Form Injection Target Dual GLP/GIP receptor agonist Clinicalread more -
![Semaglutide Oral Tablets 7mg]()
Semaglutide Oral Tablets 7mgProduct Name: Semaglutide Oral Tablet 7mg Indication Type 2 diabetes mellitus; Obesity Type Innovative Drug Form Injection Target Dual GLP/GIP receptor agonist Clinical progress Phase Ⅲread more -
![Semaglutide Tablets]()
Semaglutide TabletsProduct Name: Semaglutide tablets Indication Type 2 diabetes mellitus; Obesity Type Innovative Drug Form Injection Target Dual GLP/GIP receptor agonist Clinical progress Phase Ⅲread more -
![Argatroban Injection]()
Argatroban InjectionProduct Name: Argatroban Injection Cas. 74863-84-6 Molecular Formula C23H36N6O5S Molecular Weight 508.63 Appearance White to off-white powderread more -
![Fondaparinux Sodium Injection]()
Fondaparinux Sodium InjectionProduct Name: Fondaparinux Sodium Injection Cas. 114870-03-0 Molecular Formula C31H43N3Na10O49S8 Molecular Weight 1728.08 Appearance Colorless liquidread more -
![Eribulin Mesylate Injection]()
Eribulin Mesylate InjectionProduct Name: Eribulin Mesylate Injection Cas. 441045-17-6 Molecular Formula C41H63NO14S Molecular Weight 826.01 Appearance Colorless liquidread more -
![Oseltamivir Phosphate Suspension and Capsule]()
Oseltamivir Phosphate Suspension and CapsuleProduct Name: Oseltamivir Phosphate Suspension and Capsule Cas. 204255-11-8 Molecular Formula C16H31N2O8P Molecular Weight 410.4 Appearance White to off-white powder Storage Sealed,read more -
![Tiotropium Bromide SMI]()
Tiotropium Bromide SMIProduct Name: Tiotropium Bromide Cas. 136310-93-5 Molecular Formula C19H22BrNO4S2 Molecular Weight 472.42 Appearance White or off-white powderread more -
![Minocycline Hydrochloride LAR Injection]()
Minocycline Hydrochloride LAR InjectionProduct Name: Minocycline Hydrochloride LAR Injection Cas. 13614-98-7 Molecular Formula C23H28ClN3O7 Molecular Weight 493.94 Appearance Yellow crystalline powderread more -
![Triptorelin Pamoate LAR Injection]()
Triptorelin Pamoate LAR InjectionProduct Name: Triptorelin Pamoate LAR Injection Cas. 57773-63-4 Molecular Formula C64H82N18O13 Molecular Weight 1311.45 Appearance White to off-white powderread more
Maurice Marquez
Shipping from this supplier is fast and the quality of the product is good!
Doris Caesar
The entire transaction was very compliant and swift, showing that the company pays close attention to every detail of the buying process and is determined to bring the best shopping experience to its
Joan Winton
Your sales manager gave us a lot of advice and always put our feelings first.
Kathleen Fay
We are very honored to cooperate with you.
Linda Robinson
The product has just been received, the logistics is very fast and arrived the next morning, I like it very much, very good.
Stacey Ogata
When we received the parcel, we found a small problem, but the seller helped us solve it very well and acted very quickly. By the way, the product is good! ! !
Nature Study Reveals: AI and Molecular Dynamics Designed …...
Jul 22, 2024 — BGM0504, an AI-assisted designed dual GIP and GLP-1 receptor agonist, demonstrates superior efficacy in both in vitro and in vivo experiments. Using AI-driven...
Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the …...
Sep 1, 2022 — Certainly, the apparent advantage of tirzepatide, a dual incretin agonist, over GLP-1RA will spark renewed interest in the therapeutic potential of GIP in type 2 diabetes, obesity...
Molecular dynamics-guided optimization of BGM0504 enhances ......
Jul 19, 2024 — BGM0504 exhibited dose-dependent effects, surpassing Tirzepatide in lowering ALT levels (Fig. 4c), while such trends were not quite significant for AST (Fig. 4d)....
Designing a Dual GLP-1R/GIPR Agonist from Tirzepatide: …...
May 25, 2022 — Improving type 2 diabetes using incretin analogues is becoming increasingly plausible. Currently, tirzepatide is the most promising listed incretin analogue. Here, I briefly...
[PDF] Molecular dynamics-guided optimization of BGM0504 …...
This discovery and validation of a balanced and high-potency dual incretin agonist enables a more physiological approach to management of diseases associated with impaired glucose...
Molecular dynamics-guided optimization of BGM0504 enhances ......
Jul 19, 2024 — The dual activation of glucagon-like peptide-1 receptor (GLP-1R) and glucose-dependent insulinotropic polypeptide receptor (GIPR) has emerged as a promising therapeutic...
We are a company that continues to grow and develop, focusing not only on Ceramide NP Lipid Nanoparticle 4 6 , GMP Tirzepatide Powder Pharma Grade 99 quality management, but also on creating a good working environment. As one of the leading Incretin Analogs BGM0504 manufacturers and suppliers in China, we warmly welcome you to wholesale bulk Incretin Analogs BGM0504 in stock here from our factory. All our products are with high quality and competitive price.
Send Inquiry